Monthly Archives: March 2017

AMD Returns to Asia, as Intel Surges Towards Advanced Artificial Intelligence

NEW YORK, NY / ACCESSWIRE / March 29, 2017 / AMD will once again return to the Asian market, as the company seeks to use past experience, knowledge and execution to take the lion’s share of the market’s PC chip demands. Intel on the other hand is reorganizing its top cadre management to pave the way for Artificial Intelligence research. The share prices for the two companies are on an upward trend, with both companies closing Monday on a high.

RDI Initiates
Coverage:

Advanced Micro
Devices, Inc. https://ub.rdinvesting.com/news/?ticker=AMD

Intel Corporation https://ub.rdinvesting.com/news/?ticker=INTC

AMD’s stock closed at $13.69 on Monday, with the semiconductor manufacturer reaching a high of $13.86 and dipping to $13.55 yesterday. The company opened the day on a high, with the shares pushing the Bullish bar further right. With a 52-week high of $15.55, the micro-chip maker has fallen marginally short of consistency. The company recently announced its plans to re-enter the chip market.

Top Wall Street analyst Mark Lipacis casted a shadow of certainty regarding the move, citing confidence in the tech company’s ability to penetrate the Asian market successfully. The analyst went on to highlight better execution and high receptiveness derived from past experience as the defining factor of the company’s decision to return to the Asian PC market.

Access RDI’s Advanced Micro Devices Research Report at: https://ub.rdinvesting.com/news/?ticker=AMD

Intel’s shares have been soaring high for the past one week, with the PC hardware manufacturer opening the day yesterday at $35.39 by midday, the value had increased by 0.72% owing to the bullish nature of its stock performance, the countdown is on and all roads are heading north at the moment.

The new management is looking to revamp its top management cadre. Intel is looking to explore artificial intelligence, and a change of management was imminent. The company’s new combined unit headed by Naveen Shenoy as General Manager is an expansion of the AI labs, to facilitate production of more chips. The increased production is meant to cushion demand for chips as the company surges towards dominating the AI market.

Access RDI’s Intel Corporation Research Report at: https://ub.rdinvesting.com/news/?ticker=INTC

Our Actionable Research on Advanced Micro Devices, Inc. (NASDAQ: AMD) and Intel Corporation (NASDAQ: INTC) can be downloaded free of charge at Research Driven Investing.

Research Driven
Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Hemal K. Gandhi, a CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com

ReleaseID: 458441

Goldsource Mines Appoints Haytham Hodaly to Board

VANCOUVER, BC / ACCESSWIRE / March 29, 2017 / Goldsource Mines Inc. (TSX-V: GXS) (OTC PINK: GXSFF) (FWB: G5M) (“Goldsource” or the “Company”) is pleased to announce the appointment of Mr. Haytham Hodaly to the Board of Directors of the Company, effective March 28, 2017.

Mr. Hodaly is an engineer with a B.A.Sc. in Mining and Mineral Processing Engineering and a Master of Engineering, specializing in Mineral Economics. Mr. Hodaly is currently Senior Vice President, Corporate Development at Silver Wheaton Corp. (“Silver Wheaton”). Prior to joining Silver Wheaton in 2012, he spent 16 years in the North American securities industry, most recently as Director and Mining Analyst, Global Mining Research at RBC Capital Markets.

Ioannis Tsitos, President, stated, “We are very pleased Mr. Hodaly is joining our Board of Directors. He brings a wealth of technical and corporate expertise to Goldsource and his success on technical, corporate, and market matters will enhance our current board. We are confident that our mix of deeply experienced directors provides continuity in the strength of the Company’s leadership and good governance, for years to come.”

The Company also announces the grant of stock options under its Stock Option Plan to Mr. Hodaly for the purchase of 500,000 common shares of the Company at an exercise price of $0.16 per share for a five-year term expiring March 28, 2022. The stock option grant is subject to regulatory approval.

Ioannis (Yannis) Tsitos
President
Goldsource Mines Inc.

For Further Information:

Goldsource Mines Inc.
Contact: Ioannis (Yannis) Tsitos, President
Fred Cooper, Investor Relations
Telephone: +1 (604) 694-1760
Fax: +1 (604) 694-1761
Toll Free: 1-866-691-1760 (Canada & USA)
Email: info@goldsourcemines.com
Website: www.goldsourcemines.com
570 Granville Street, Suite 501
Vancouver, British Columbia V6C 3P1

Neither TSX-V nor its Regulation Services Provider (as that term is defined in policies of the TSX-V) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Goldsource Mines Inc.

ReleaseID: 458461

Las Vegas Valley Home Security Monitoring Camera Systems Alarms Site Launched

A website has been launched by National Security Alarms. The Las Vegas security company help residents protect their homes from burglaries with state of the art security and surveillance systems.

Las Vegas, United States – March 29, 2017 /PressCable/

A Las Vegas based security company, National Security Alarms, has launched a new website. National Security Alarms help people in Las Vegas to protect their properties from crime by installing their security systems in customers homes and businesses.

For more information please visit: http://nsasecuritysystems.com.

National Security Alarms specialize in home security alarms and camera systems. They provide the latest technology in home security to the Las Vegas valley. They have been in operation since 2008 and are a locally owned and run business.

The site explains that home protection is of upmost importance in the current day. Crime rates in Las Vegas have increased by 9.5% since 2009. In 2013 14,785 burglaries were attended in Las Vegas, which is an average of 41 burglaries a days. That breaks down to burglaries taking place every 35 minutes.

The company can help to prevent burglaries and protect homes with their security systems. The systems are all controlled through a tablet center point that can be controlled remotely with a tablet, pc or cell phone, giving access even when away from home. Cameras can be place in any area of the home, inside and out.

Remote access can alert the home owner in the case of fire alarms, carbon monoxide and burglaries. In the case of an emergency the appropriate emergency service is contacted to dispatch assistance to customer’s home immediately. National Security Alarms are also available with support for their client’s 24 hours a day, seven days a week.

The website showcases the three packages that the company offers. The basic package comprises of free basic equipment, free installation and lifetime warranty. It is also backed by the 24 hour support provided. The next two packages have the basic elements and extras such as pet sensitive motion detectors, keychain remotes and security signs. All are available on a monthly payment plan.

Those wishing to find out more about home security in Las Vegas can visit the website on the link provided above.

Contact Info:
Name: Gary Bender
Organization: National Security Alarms
Address: 6525 W Warm Springs Rd #150, Las Vegas, NV 89118, United States
Phone: +1-702-736-1305

For more information, please visit http://nsasecuritysystems.com/

Source: PressCable

Release ID: 181467

Synthetic Spider Silk Market Analysis by Genetically Modified Yeast Fermentation, Silkworm, E. Coli Fermentation and Others Type 2017 – 2022

Global Synthetic Spider Silk Market by Manufacturers, Countries, Type and Application, Forecast to 2022 report describes Synthetic Spider Silk sales channel, distributors, traders, dealers, sales, revenue and market share.

Pune, India – March 29, 2017 /MarketersMedia/

Global Synthetic Spider Silk Market 2017 – 2022 Report displays the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017. It provides the global market by regions, with sales, revenue and market share of Synthetic Spider Silk, for each region, from 2012 to 2017.

Browse 152 Tables and Figures, 4 Companies, spread across 118 pages available at http://www.reportsnreports.com/reports/926006-global-synthetic-spider-silk-market-by-manufacturers-countries-type-and-application-forecast-to-2022.html.

This report focuses on the Global Synthetic Spider Silk Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers: Bolt Threads, Kraig Biocraft Laboratories, Spiber, AMSilk

Market Segment by Regions, regional analysis covers: North America (USA, Canada and Mexico); Europe (Germany, France, UK, Russia and Italy); Asia-Pacific (China, Japan, Korea, India and Southeast Asia); South America (Brazil, Argentina, Columbia etc.); Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers: Genetically Modified Yeast Fermentation, Genetically Modified Silkworm, Genetically Modified E. Coli Fermentation, Others

Market Segment by Applications, can be divided into: Automobile, Textile, Health Care, Military, Other

Order a Copy of Report at http://www.reportsnreports.com/purchase.aspx?name=926006.

Global Synthetic Spider Silk market report describes Synthetic Spider Silk Introduction, product scope, market overview, market opportunities, market risk, market driving force. It also analyses the top manufacturers of Synthetic Spider Silk, with sales, revenue, and price of Synthetic Spider Silk, in 2016 and 2017. The report displays the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017. And also shows the global market by regions, with sales, revenue and market share of Synthetic Spider Silk, for each region, from 2012 to 2017.

Market study analyses the key regions, with sales, revenue and market share by key countries in these regions. It shows the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017. The report provides Synthetic Spider Silk market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022. In the end it also describes Synthetic Spider Silk sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Get Discount at http://www.reportsnreports.com/contacts/discount.aspx?name=926006.

List of Tables and Figures
Figure Synthetic Spider Silk Picture
Table Product Specifications of Synthetic Spider Silk
Figure Global Sales Market Share of Synthetic Spider Silk by Types in 2016
Table Synthetic Spider Silk Types for Major Manufacturers
Figure Genetically Modified Yeast Fermentation Picture
Figure Genetically Modified Silkworm Picture
Figure Genetically Modified E. Coli Fermentation Picture
Figure Others Picture
Table Synthetic Spider Silk Sales Market Share by Applications in 2016
Figure Automobile Picture
Figure Textile Picture
Figure Health Care Picture
Figure Military Picture
Figure Other Picture
Figure USA Synthetic Spider Silk Revenue (Value) and Growth Rate (2012-2022)
Figure Canada Synthetic Spider Silk Revenue (Value) and Growth Rate (2012-2022)
Figure Mexico Synthetic Spider Silk Revenue (Value) and Growth Rate (2012-2022)
Figure Germany Synthetic Spider Silk Revenue (Value) and Growth Rate (2012-2022)
Figure France Synthetic Spider Silk Revenue (Value) and Growth Rate (2012-2022)
Figure UK Synthetic Spider Silk Revenue (Value) and Growth Rate (2012-2022)
And more.

About Us
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Contact Info:
Name: Ritesh Tiwari
Email: sales@reportsandreports.com
Organization: ReportsnReports.com
Phone: + 1 888 391 5441

Source URL: http://marketersmedia.com/synthetic-spider-silk-market-analysis-by-genetically-modified-yeast-fermentation-silkworm-e-coli-fermentation-and-others-type-2017-2022/181351

For more information, please visit http://www.reportsnreports.com/reports/926006-global-synthetic-spider-silk-market-by-manufacturers-countries-type-and-application-forecast-to-2022.html

Source: MarketersMedia

Release ID: 181351

How Will Rapid Cholesterol Test Relate to Potential Future Revenue for Akers

NEW YORK, NY / ACCESSWIRE / March 29, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and micro-cap public companies is issuing a comprehensive report with no obligation on Akers Biosciences Inc (NASDAQ: AKER). Akers has three lines generating revenue including Clinical Diagnostics, Safety Diagnostics & Wellness. Under these segments, it is developing proprietary, diagnostic technologies that increase the frequency at which clinicians, and in some cases consumers, can get accurate health information and has a number of products in their portfolio.

Aker recently announced that it received an initial order for the Company’s rapid cholesterol self-test from First Check Diagnostics, LLC (“First Check”), the exclusive distributor for this product in the United States, for sale under their popular “First Check” brand.

The following report provides a comprehensive review of the market for the “First Check” product READ MORE

Copy and paste to your browser may be required to view the report- http://tradersnewssource.com/akers-biosciences/

Point-of-care diagnostics is a multi-billion dollar health care market that is well poised for robust growth over the near to medium term and with over 73 million adults in the US deemed to have high bad cholesterol, Aker should have a strong order book & opportunities around rapid cholesterol test. The company is aggressively focusing on building this revenue stream with its distribution partner and providing consumers with a fast, convenient and meaningful way to evaluate and manage their cholesterol.

This full report looks at market size, potential revenues and current financial situation for Akers READ MORE

Copy and paste to your browser may be required to view the report- http://tradersnewssource.com/akers-biosciences/

DISCLOSURE

Traders News Source LLC (TNS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering small and micro-cap equity markets. TNS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE, NASDAQ and OTC exchanges. The other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TNS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a chartered financial analyst, for further information on analyst credentials, please email editor@tradersnewssource.com. Vikas Agrawal, a CFA® charter holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written, and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author per the procedures outlined by TNS. TNS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents, or reports. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

TNS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake, or shortcoming. No liability is accepted whatsoever for any direct, indirect, or consequential loss arising from the use of this document. TNS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, TNS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.tradersnewssource.com.

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer be featured on our coverage list, contact us via email at: editor@tradersnewssource.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT:

editor@tradersnewssource.com

SOURCE: Traders News Source

ReleaseID: 458460

Kotton Grammer Reveals Shocking Facts About YouTube Disappearance

KGR Club launches a new YouTube Channel aimed at Enrepreneurs that plans to cover Leveraging Search Engine Optimization to rank websites organically, apart from paid ads, such as Google pay-per-click (PPC). The channel and the extensive video content can be found at https://www.youtube.com/channel/UCw37LYaxQnQ-Lv-gX34r7sw

Kotton Grammer Reveals Shocking Facts About YouTube Disappearance

Sacramento, United States – March 29, 2017 /PressCable/

Many of his die-hard legions and loyal viewers from around the world wondered what happened to Kotton and why he took that long hiatus from YouTube. After six months of muteness, he returns and finally revealed long awaited answers to a handful of followers. Kotton, the self-made SEO who ranks for the number one spot across forty cities around the world, claimed the primary reason why he disappeared was due to a revamp in philosophy and rerunning of what mattered the most to him – his YouTube channel.

Entrepreneurs, who were questioning and looking for the latest information on Leveraging Search Engine Optimization to rank websites organically, apart from paid ads, such as Google pay-per-click (PPC) are invited to subscribe to the all-new YouTube channel by KGR Club. This new channel promises to provide expert guidance and information on Leveraging Search Engine Optimization or SEO to rank websites organically, apart from paid ads, such as Google pay-per-click (PPC), on a regular basis.

This new YouTube channel was created specifically with the needs of people who embrace entrepreneurship and would like to be their own boss and live a lifestyle not dependent upon money, time, and location in mind, and KGR Club welcomes input on which topics to explore.

Kaylee Storm, Director of Marketing at KGR Club said: “It appears there are a lot of confusion out there in the Internet Marketing world on Kotton Grammer, who he is and what he represents. There have even been fake Kotton Grammer review rip-off reports fabricated to just slander the character of Kotton Grammer. Many in the field have been working with Kotton for years and want to inform as well as provide to the public real facts to understanding that Kotton Grammer is indeed a man of the highest character and integrity.”

KGR Club’s Director of Marketing goes on to say: “The aim of the new YouTube Channel is to educate the public on the work and character of Kotton Grammer so that they can make an unbiased judgement for themselves. The more feedback the club receives, the better and more accurate it can serve its audience.” This was followed by a plethora of fans leaving a Kotton Grammer testimonial.

After the new YouTube channel launched on March 15, 2017, new viewers can catch up and view all the latest videos here: https://www.youtube.com/channel/UCgjgEb0ypz1-brfchb_u3dQ .

Further details on the channel, the direction and other information on KGR Club itself can be found from their website at: http://www.kottongrammerreview.club/

Contact Info:
Name: Guy Nicks
Organization: Information Technology of Sacramento (ITCS)
Address: 372 Florin Road, Sacramento, CA 95831, United States

For more information, please visit http://www.itconsultingsacramento.net

Source: PressCable

Release ID: 181253

Cavitation Technologies, Inc (CVAT) Announces a Licensing Agreement with Industry Leader GEA Group AG, Westfalia

CHATSWORTH, CA / ACCESSWIRE / March 29, 2017 / Cavitation Technologies, Inc (CTI) (OTCQB: CVAT; Berlin: WTC) announced today that GEA Group AG, Westfalia (GEA) (Frankfurt: G1A) have entered into a new global technology license, R&D and marketing agreement with respect to CTi’s patented Nano Reactor™ technology, processes and applications. Under the new agreement, GEA has been granted a worldwide exclusive license to integrate CTi’s patented technology into water treatment application, milk and juice pasteurization, and certain food related processes. The license agreement between CTi and GEA has a three year term and provides $300,000 per year in advanced license fees to CTi.

Igor Gorodnitsky, CTi’s President commented, “This is an important milestone for our company to expand our relationship with GEA in order to make our technology available on a worldwide basis. We believe that GEA, being one of the world’s leading engineering firms in diversified industries, is uniquely positioned to market and sell our technology and processes. Longer term, this is an extraordinary opportunity for our company to deliver accelerated acceptance of our technology, sales growth and increased shareholder value, thus allowing us to focus on research and development of new technologies and applications.”

About CTi

Founded in 2007, the company designs and manufactures state-of-the-art, flow-through, devices and systems as well as develops processing technologies for use in edible oil refining, renewable fuel production, expeditious petroleum upgrading, algal oil extraction, alcoholic beverage enhancement, water treatment, and the extraction of cannabidiol (CBD). As an add-on to its existing neutralization systems, the company’s patented Nano Reactor™ allows refiners to significantly reduce both processing costs and environmental impact, while also increasing yield. http://www.ctinanotech.com/

Follow us on Twitter for real time updates: https://twitter.com/cavitationtech

Like us on Facebook to receive live feeds updates: https://www.facebook.com/ctinanotech

About GEA

GEA is one of the largest suppliers for the food processing industry and a wide range of process industries that generated consolidated revenues of approximately EUR 4.6 billion in 2015. As an international technology group, the Company focuses on process technology and components for sophisticated production processes in various end-user markets. The Group generates more than 70 percent of its revenue in the food sector that enjoys long-term sustainable growth. As of December 31, 2016, the Company employed about 17,000 people worldwide. GEA is a market and technology leader in its business areas. The Company is listed on the German MDAX (G1A, WKN 660 200). In addition, GEA’s share is a constituent of the MSCI Global Sustainability Indexes. Further information is available on the Internet at gea.com. If you do not want to receive any further information from GEA, please send an email to pr@gea.com

Forward Looking Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions, and include statements regarding the anticipated installation and the timing of the installation, our intent to continue to focus on research and development, marketing and sales of our unique technology, our belief that our company is positioned for accelerated growth and the expected efforts to be made to enhance our shareholder’s value. These forward-looking statements are based largely on the Company’s expectations and are subject to a number of risks and uncertainties, certain of which are beyond the Company’s control. Actual results could differ materially from these forward looking statements as a result of a variety of factors including, among others, the state of the economy, the competitive environment and our ability to perform the installation as anticipated and other factors described in our most recent Form 10-K and our other filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. In light of these risks and uncertainties there can be no assurances that the forward looking statements contained in this press release will in fact transpire or prove to be accurate. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

Cavitation Technologies, Inc.

Contact:

Investor Relations
IR@ctinanotech.com
http://cvat.info/
Phone (818) 718-0905

SOURCE: Cavitation Technologies, Inc.

ReleaseID: 458410

Research Reports Initiated on Financials Stocks Great-West Lifeco, Intact Financial, Input Capital, and Inspira Financial

LONDON, UK / ACCESSWIRE / March 29, 2017 / Active Wall St. announces the list of stocks for today’s research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Financial Services Sector. Companies recently under review include Great-West Lifeco, Intact Financial, Input Capital, and Inspira Financial. Get all of our free research reports by signing up at:

http://www.activewallst.com/register/

On Tuesday, March 28, 2017, the Toronto Exchange Composite Index was up 0.60%, finishing the day at 15,598.57. The TSX Venture Composite Index, on the other hand, closed at 804.12, flat.

Additionally, the Financials index was slightly up by 0.90%, ending the session at 291.17.

Active Wall St. has initiated research reports on the following equities: Great-West Lifeco Inc. (TSX: GWO), Intact Financial Corporation (TSX: IFC), Input Capital Corporation (TSX-V: INP), and Inspira Financial Inc. (TSX-V: LND). Register with us now for your free membership and research reports at:

http://www.activewallst.com/register/

Great-West Lifeco Inc.

Winnipeg, Canada-based Great-West Lifeco Inc.’s stock edged 0.95% higher, to finish Tuesday’s session at $37.33 with a total volume of 541,987 shares traded. Over the last one month and the previous three months, Great-West Lifeco’s shares have advanced 3.01% and 5.60%, respectively. Furthermore, the stock has gained 5.36% in the past one year. The Company’s shares are trading above its 50-day and 200-day moving averages. Great-West Lifeco’s 50-day moving average of $36.94 is above its 200-day moving average of $35.03. Shares of the Company, which engages in life and health insurance, asset management, investment and retirement savings, and reinsurance businesses in Canada, the US, Europe, and Asia, are trading at a PE ratio of 14.02. See our research report on GWO.TO at:

http://www.activewallst.com/register/

Intact Financial Corp.

On Tuesday, shares in Toronto, Canada-based Intact Financial Corp. recorded a trading volume of 255,199 shares, which was above their three months average volume of 207,077 shares. The stock ended the day 0.02% higher at $94.39. Intact Financial’s stock has advanced 0.24% in the last one month and 4.40% in the previous one year. The Company’s shares are trading above its 200-day moving average. The stock’s 50-day moving average of $94.95 is above its 200-day moving average of $94.08. Shares of the Company, which through its subsidiaries, provides property and casualty insurance products to individuals and businesses in Canada, are trading at PE ratio of 23.77. The complimentary research report on IFC.TO at:

http://www.activewallst.com/register/

Input Capital Corp.

On Tuesday, shares in Regina, Canada headquartered Input Capital Corp. ended the session flat at $1.83 with a total volume of 33,900 shares traded. Input Capital’s shares have gained 2.23% in the last one month and 14.38% in the previous one year. Shares of the Company, which operates as an agricultural commodity streaming company in Canada, are trading above its 50-day moving average. Furthermore, the stock’s 200-day moving average of $1.84 is greater than its 50-day moving average of $1.80. Register for free and access the latest research report on INP.V at:

http://www.activewallst.com/register/

Inspira Financial Inc.

Walnut Creek, California headquartered Inspira Financial Inc.’s stock closed the day flat at $0.27. The stock recorded a trading volume of 135,729 shares. Shares of the Company, which together with its subsidiaries, provides asset-based financial services to healthcare providers and their patients in the US, are trading below their 50-day moving average of $0.71. Get free access to your research report on LND.V at:

http://www.activewallst.com/register/

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 458427

CVR Medical Announces Amended Financing Price

VANCOUVER, BC / ACCESSWIRE / March 29, 2017 / CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) (“CVR Medical”) previously announced its intention to complete a private placement financing of units for gross proceeds of up to $5,000,000 (the “Financing”), at a proposed price of $0.45 per unit. After consultation with the TSX Venture Exchange, CVR Medical has amended the proposed purchase price of the Financing to $0.48 per unit. All other aspects of the Financing remain unchanged.

Completion of the Financing is subject to Exchange acceptance, and all securities issued pursuant to the Financing will be subject to a hold period of four months in accordance with applicable securities legislation.

The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

For additional information on the organization, leadership, and current news please visit the company website at www.CVRMed.com

About CVR Medical

CVR Medical is a company that is involved in an equal parts joint venture with CVR Global Inc. (the “Joint Venture”). The Joint Venture operates in the medical industry focused on the commercialization of a proprietary subsonic, infrasonic, and low frequency sound wave analysis technology and has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. CVR Medical is managed by a proven technical team. CVR Medical trades on the TSX Venture Exchange under the symbol CVM.

ON BEHALF OF THE BOARD:

(signed) “Peter Bakema”
CEO, President & Director

For further information contact:

Brisco Capital Partners Corp.
Scott Koyich, President
Telephone: (403) 262-9888

This press release contains forward-looking information that involves various risks and uncertainties regarding future events related to the Joint Venture and the proposed Financing. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements and are not guarantees of future performance of the Company. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. These forward-looking statements reflect management’s current views and are based on certain expectations, estimates and assumptions which may prove to be incorrect. A number of risks and uncertainties could cause our actual results to differ materially from those expressed or implied by the forward-looking statements, including: (1) a downturn in general economic conditions in North America and internationally, (2) the inherent uncertainties and speculative nature associated with commercialization of technology and the practice of medicine, (3) a change in health regulations, (4) any number of events or causes which may delay or cease commercialization and development of the Joint Venture, (5) the risk that the Company or the Joint Venture does not execute its business plan, (6) inability to retain key employees, (7) inability to finance operations and growth, and (8) other factors beyond the Company’s control. These forward-looking statements are made as of the date of this news release and, except as required by law, the Company assumes no obligation to update these forward-looking statements, or to update the reasons why actual results differed from those projected in the forward-looking statements.

THE TSX VENTURE EXCHANGE INC. HAS NEITHER APPROVED NOR DISAPPROVED THE CONTENTS OF THIS PRESS RELEASE. NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

SOURCE: CVR Medical Corp.

ReleaseID: 458459

Research Reports Initiated on Healthcare Stocks BELLUS Health, Resverlogix, Helius Medical Technologies, and IntelliPharmaCeutics International

LONDON, UK / ACCESSWIRE / March 29, 2017 / Active Wall St. announces the list of stocks for today’s research reports. Pre-market the Active Wall St. team provides the technical coverage impacting selected stocks trading on the Toronto Exchange and belonging under the Biotechnology industry. Companies recently under review include BELLUS Health, Resverlogix, Helius Medical Technologies, and IntelliPharmaCeutics International. Get all of our free research reports by signing up at:

http://www.activewallst.com/register/

At the close of the Canadian markets on Tuesday, March 28, 2017, the Toronto Exchange Composite index ended the trading session at 15,598.57, 0.60% higher from its previous closing price.

The Healthcare Index was in the red, closing the day at 67.85, down 0.29%.

Active Wall St. has initiated research reports on the following equities: BELLUS Health Inc. (TSX: BLU), Resverlogix Corporation (TSX: RVX), Helius Medical Technologies Inc. (TSX: HSM), and IntelliPharmaCeutics International Inc. (TSX: IPCI). Register with us now for your free membership and research reports at:

http://www.activewallst.com/register/

BELLUS Health Inc.

Laval, Canada-based BELLUS Health Inc.’s stock declined 1.82%, to finish Tuesday’s session at $0.27 with a total volume of 49,820 shares traded. Shares of the Company, which together with its subsidiaries, focuses on the research and development of drugs for rare diseases, are trading below its 50-day moving average. BELLUS Health’s 50-day moving average of $0.28 is above its 200-day moving average of $0.27. See our research report on BLU.TO at:

http://www.activewallst.com/register/

Resverlogix Corp.

On Tuesday, shares in Calgary, Canada headquartered Resverlogix Corp. recorded a trading volume of 40,140 shares. The stock ended the day 3.60% higher at $2.30. Resverlogix’s stock has surged 13.30% in the last one month and 37.72% in the previous three months. Furthermore, the stock has rallied 82.54% in the past one year. Shares of the Company, which develops small molecule therapeutics for Bromodomain and ExtraTerminal (BET) inhibition, are trading above its 50-day and 200-day moving averages. The stock’s 50-day moving average of $2.04 is above its 200-day moving average of $1.89. The complimentary research report on RVX.TO at:

http://www.activewallst.com/register/

Helius Medical Technologies Inc.

On Tuesday, shares in Newtown, Pennsylvania headquartered Helius Medical Technologies Inc. ended the session 0.48% higher at $2.09 with a total volume of 23,715 shares traded. Helius Medical Technologies’ shares have gained 12.97% in the last three months and 90.00% in the previous one year. Shares of the Company, which operates as a medical technology company focused on neurological wellness, are trading above its 200-day moving average. Furthermore, the stock’s 50-day moving average of $2.14 is greater than its 200-day moving average of $1.94. Register for free and access the latest research report on HSM.TO at:

http://www.activewallst.com/register/

IntelliPharmaCeutics International Inc.

Toronto, Canada-based IntelliPharmaCeutics International Inc.’s stock closed the day 2.55% higher at $3.22. The stock recorded a trading volume of 4,100 shares. IntelliPharmaCeutics International’s shares have advanced 2.55% in the last one month. Shares of the Company, which develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in Canada, are trading above its 50-day moving average of $3.07. Get free access to your research report on IPCI.TO at:

http://www.activewallst.com/register/

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street

ReleaseID: 458428